STOCK PURCHASE AGREEMENTStock Purchase Agreement • October 3rd, 2018 • BioLineRx Ltd. • Pharmaceutical preparations
Contract Type FiledOctober 3rd, 2018 Company IndustryThis Stock Purchase Agreement (the “Agreement”) is entered into as of October 2, 2018 (the “Effective Date”) by and between BioLineRx Ltd., an Israeli company having a place of business at 2 HaMa’ayan Street, Modi’in 7177871 (“BioLine”), and Biokine Therapeutics Ltd., an Israeli company having a place of business at Weizmann Science Park, P.O. Box 2213, Rehovot, 76120 (“Biokine”). Biokine and BioLine are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
AGREEMENT FOR THE PROVISION OF A LOAN FACILITY OF UP TO US$ 10,000,000 Dated October 2, 2018 BetweenAgreement • October 3rd, 2018 • BioLineRx Ltd. • Pharmaceutical preparations
Contract Type FiledOctober 3rd, 2018 Company IndustryKREOS CAPITAL V (EXPERT FUND) L.P. a company incorporated in Jersey whose registered office is at 47 Esplanade, St Helier, Jersey (the “Lender”, which expression shall include its successors and assigns);
ContractBioLineRx Ltd. • October 3rd, 2018 • Pharmaceutical preparations
Company FiledOctober 3rd, 2018 IndustryTHIS WARRANT AND THE SECURITIES REPRESENTED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISPOSITION THEREOF. NO SUCH SALE OR DISPOSITION MAY BE AFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.
AMENDMENT AGREEMENTAmendment Agreement • October 3rd, 2018 • BioLineRx Ltd. • Pharmaceutical preparations
Contract Type FiledOctober 3rd, 2018 Company IndustryTHIS AMENDMENT AGREEMENT (the “Agreement”) is entered into effective as of October 2, 2018 (the “Effective Date”), is entered into by and between BioLineRx Ltd., an Israeli company having a place of business at 2 HaMa’ayan Street, Modi’in 7177871 (“BioLine”), and Biokine Therapeutics Ltd., an Israeli company having a place of business at Weizmann Science Park, P.O. Box 2213, Rehovot, 76120 (“Biokine”).